LUNG vs CTKB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

LUNG

50.7
AI Score
VS
LUNG Wins

CTKB

47.6
AI Score

Investment Advisor Scores

LUNG

51score
Recommendation
HOLD

CTKB

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LUNG CTKB Winner
Forward P/E 28.3286 370.3704 LUNG
PEG Ratio 0 0 Tie
Revenue Growth -4.6% 6.5% CTKB
Earnings Growth 0.0% 73.5% CTKB
Tradestie Score 50.7/100 47.6/100 LUNG
Profit Margin -55.0% -36.2% CTKB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LUNG 1M: +52.5% · 3M: +57.0% CTKB 1M: -6.1% · 3M: -6.7%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 78

RSI (14): 77.5 · Price: $2.12

CTKB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.8 · Price: $4.31

Fundamentals Snapshot

Metric LUNG CTKB
Market Cap
Forward P/E -2.3 21.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.8% 0.5%
Operating Margin -0.4% -0.4%
EPS -1.15 -0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.